|
Editor-in-Chief:
GARY R. EPLER, MD, FCCP
Boston, Massachusetts
Deputy Editor:
STEVEN A. SAHN, MD, FCCP
Charleston, South Carolina
Editorial
Board
ACCP Staff:
ALVIN LEVER
Executive Vice President and CEO
DAVID H. EUBANKS, EdD, RRT
Vice President, Education
ARLENE KARAVICH
PCCU Program Coordinator
AMY REYNALDO
Copy Editor
A. DOUGLAS TIPTON
Web Design
Accreditation Statement
The American College of Chest Physicians is accredited by the Accreditation
Council for Continuing Medical Education to provide continuing
medical education for physicians. The American College of Chest
Physicians takes responsibility for the content, quality, and
scientific integrity of this CME activity.
CME Credit
The ACCP designates this continuing medical education activity
for up to 24 credit hours (1 credit per lesson) in Category 1
of the Physician’s Recognition Award of the American Medical
Association.
|
|
Update on a1-Antitrypsin
Deficiency
By Charlie Strange, MD, FCCP
Dr. Strange is at the Medical University
of South Carolina, Charleston.
Stage IIIA Non-Small Cell Lung Cancer: Evaluating and
Treating Patients With N2 Disease
By Aminah Jatoi, MD; and James R. Jett,
MD, FCCP
Dr. Jatoi is Assistant Professor and Consultant
in Medical Oncology, Mayo Clinic, Rochester, MN; Dr. Jett
is Professor of Medicine and Consultant in Thoracic Diseases
and Medical Oncology, Mayo Clinic.
PCCU is a publication of the
American College of Chest Physicians
3300 Dundee Road
Northbrook, IL 60062-2348
© 2002, American College
of Chest Physicians
ISSN #1047-4145
|
